DANE HALLBERG

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

TITAN PHARMACEUTICALS INC

Filing Date Source Excerpt
2020-01-31 Dane Hallberg(6) Represents shares issuable upon exercise of outstanding options.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22